Compare Stocks: EHAB, PRVA, AVAH, and CLOV

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVAH Aveanna Healthcare	$13.90 +5.6%	$9.58	$5.93 ▼ $13.95	$3.03B	1.9	1.77 million shs	775,477 shs
CLOV Clover Health Investments	$4.15 -0.1%	$4.68	$1.58 ▼ $5.59	$2.20B	2.47	6.32 million shs	474,165 shs
EHAB Enhabit	$13.80	$13.79	$6.47 ▼ $14.22	$706.97M	1.26	1.05 million shs	1.38 million shs
PRVA Privia Health Group	$21.14 +0.1%	$24.58	$19.53 ▼ $28.82	$2.70B	0.85	990,151 shs	34,896 shs

7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVAH Aveanna Healthcare	0.00%	+6.82%	+39.26%	+79.54%	+76.17%
CLOV Clover Health Investments	0.00%	-9.78%	-3.94%	+16.90%	+52.01%
EHAB Enhabit	0.00%	0.00%	0.00%	0.00%	+68.93%
PRVA Privia Health Group	0.00%	-4.00%	-17.18%	-7.33%	-3.96%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVAH Aveanna Healthcare	$13.90 +5.6%	$9.58	$5.93 ▼ $13.95	$3.03B	1.9	1.77 million shs	775,477 shs
CLOV Clover Health Investments	$4.15 -0.1%	$4.68	$1.58 ▼ $5.59	$2.20B	2.47	6.32 million shs	474,165 shs
EHAB Enhabit	$13.80	$13.79	$6.47 ▼ $14.22	$706.97M	1.26	1.05 million shs	1.38 million shs
PRVA Privia Health Group	$21.14 +0.1%	$24.58	$19.53 ▼ $28.82	$2.70B	0.85	990,151 shs	34,896 shs

7 Stocks to Buy Before the Robotics Revolution

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVAH Aveanna Healthcare	0.00%	+6.82%	+39.26%	+79.54%	+76.17%
CLOV Clover Health Investments	0.00%	-9.78%	-3.94%	+16.90%	+52.01%
EHAB Enhabit	0.00%	0.00%	0.00%	0.00%	+68.93%
PRVA Privia Health Group	0.00%	-4.00%	-17.18%	-7.33%	-3.96%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AVAH Aveanna Healthcare	2.67	Moderate Buy	$12.44	-10.45% Downside
CLOV Clover Health Investments	2.00	Hold	$4.33	4.54% Upside
EHAB Enhabit	2.11	Hold	$13.57	-1.66% Downside
PRVA Privia Health Group	2.79	Moderate Buy	$31.00	46.63% Upside

Current Analyst Ratings Breakdown

Latest EHAB, PRVA, AVAH, and CLOV Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/24/2026	AVAH Aveanna Healthcare	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$10.00 ➝ $16.00
8/14/2026	AVAH Aveanna Healthcare	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Strong-Buy	$13.00 ➝ $15.00
8/14/2026	AVAH Aveanna Healthcare	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$8.00 ➝ $13.00
8/14/2026	AVAH Aveanna Healthcare	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$10.00 ➝ $14.00
8/7/2026	PRVA Privia Health Group	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$32.00
8/6/2026	CLOV Clover Health Investments	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$4.75 ➝ $5.00
8/5/2026	PRVA Privia Health Group	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
7/23/2026	PRVA Privia Health Group	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
7/21/2026	CLOV Clover Health Investments	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$4.20 ➝ $5.50
7/14/2026	AVAH Aveanna Healthcare	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Hold	$9.00 ➝ $11.00
7/9/2026	AVAH Aveanna Healthcare	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$9.00 ➝ $9.50

(Data available from 8/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AVAH Aveanna Healthcare	$2.43B	1.25	$0.73 per share	19.08	$0.93 per share	14.94
CLOV Clover Health Investments	$2.48B	0.89	N/A	N/A	$0.59 per share	7.03
EHAB Enhabit	$1.06B	0.67	$1.96 per share	7.04	$11.30 per share	1.22
PRVA Privia Health Group	$2.12B	1.27	$0.27 per share	79.14	$6.43 per share	3.29

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AVAH Aveanna Healthcare	$225.03M	$1.23	11.30	18.29	0.92	10.56%	80.70%	7.42%	11/5/2026 (Estimated)
CLOV Clover Health Investments	-$85.55M	-$0.05	N/A	N/A	N/A	-0.74%	-4.20%	-2.28%	11/4/2026 (Estimated)
EHAB Enhabit	-$4.60M	-$0.09	N/A	21.56	N/A	-0.30%	7.24%	3.48%	N/A
PRVA Privia Health Group	$22.92M	$0.21	100.68	51.57	1.67	1.19%	3.52%	2.00%	11/5/2026 (Estimated)

Latest EHAB, PRVA, AVAH, and CLOV Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2026	Q2 2026	AVAH Aveanna Healthcare	$0.1683	$0.22	+$0.0517	$0.18	$638.61 million	$670.48 million
8/6/2026	Q2 2026	PRVA Privia Health Group	$0.0674	$0.19	+$0.1226	$0.07	$597.33 million	$632.63 million
8/5/2026	Q2 2026	CLOV Clover Health Investments	$0.0386	$0.05	+$0.0114	$0.05	$728.27 million	$743.17 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AVAH Aveanna Healthcare	N/A	N/A	N/A	N/A	N/A
CLOV Clover Health Investments	N/A	N/A	N/A	N/A	N/A
EHAB Enhabit	N/A	N/A	N/A	N/A	N/A
PRVA Privia Health Group	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AVAH Aveanna Healthcare	4.47	1.16	1.16
CLOV Clover Health Investments	N/A	1.50	1.50
EHAB Enhabit	0.70	1.56	1.56
PRVA Privia Health Group	N/A	1.62	1.62

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AVAH Aveanna Healthcare	87.96%
CLOV Clover Health Investments	19.77%
EHAB Enhabit	N/A
PRVA Privia Health Group	94.48%

Insider Ownership

Company	Insider Ownership
AVAH Aveanna Healthcare	5.30%
CLOV Clover Health Investments	23.51%
EHAB Enhabit	3.40%
PRVA Privia Health Group	5.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AVAH Aveanna Healthcare	35,500	218.22 million	206.65 million	Optionable
CLOV Clover Health Investments	680	531.16 million	406.28 million	Optionable
EHAB Enhabit	10,800	51.23 million	49.48 million	Optionable
PRVA Privia Health Group	1,226	127.73 million	120.45 million	Optionable

EHAB, PRVA, AVAH, and CLOV Headlines

Recent News About These Companies

Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors

August 18, 2026 | markets.businessinsider.com

Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors

August 18, 2026 | globenewswire.com

Bank of America Corp DE Cuts Holdings in Privia Health Group, Inc. $PRVA

August 18, 2026 | marketbeat.com

OneDigital Investment Advisors LLC Purchases New Stake in Privia Health Group, Inc. $PRVA

August 17, 2026 | marketbeat.com

GSA Capital Partners LLP Invests $1.67 Million in Privia Health Group, Inc. $PRVA

August 17, 2026 | marketbeat.com

Oppenheimer Asset Management Inc. Purchases New Stake in Privia Health Group, Inc. $PRVA

August 16, 2026 | marketbeat.com

Truist Financial Remains a Buy on Privia Health Group (PRVA)

August 14, 2026 | theglobeandmail.com

Privia Health’s (PRVA) Guidance Keeps Rising, So Is The Stock Keeping Pace?

August 13, 2026 | insidermonkey.com

Privia Health Group (PRVA) Gets a Buy from Citi

August 12, 2026 | theglobeandmail.com

Privia Health Group (PRVA) Is Down 5.2% After Raising 2026 Revenue Guidance And Expanding Footprint

August 10, 2026 | finance.yahoo.com

BMO Capital Keeps Their Buy Rating on Privia Health Group (PRVA)

August 9, 2026 | theglobeandmail.com

Evercore ISI Remains a Buy on Privia Health Group (PRVA)

August 8, 2026 | theglobeandmail.com

Privia Health earnings call highlights growth and margins

August 8, 2026 | theglobeandmail.com

PRVA Q2 deep dive: Revenue growth outpaces profit as margin expansion remains in focus

August 8, 2026 | msn.com

Sei Investments Co. Cuts Stock Position in Privia Health Group, Inc. $PRVA

August 8, 2026 | marketbeat.com

Privia Health Group (NASDAQ:PRVA) Stock Rating Upgraded by Zacks Research

August 7, 2026 | marketbeat.com

Privia Health Group Q2 Earnings Call Highlights

August 7, 2026 | marketbeat.com

Privia Health Group, Inc. 2026 Q2 - Results - Earnings Call Presentation

August 7, 2026 | seekingalpha.com

Privia Health targets high end of 30% to 35% EBITDA-to-care margin range as it raises 2026 outlook

August 6, 2026 | seekingalpha.com

Privia Health Group (NASDAQ:PRVA) Shares Gap Down - Should You Sell?

August 6, 2026 | marketbeat.com

Compared to Estimates, Privia Health (PRVA) Q2 Earnings: A Look at Key Metrics

August 6, 2026 | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

EHAB, PRVA, AVAH, and CLOV Company Descriptions

Aveanna Healthcare NASDAQ:AVAH

$13.90 +0.74 (+5.60%)

As of 10:24 AM Eastern

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.

Clover Health Investments NASDAQ:CLOV

$4.14 -0.01 (-0.12%)

As of 10:24 AM Eastern

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.

Enhabit NYSE:EHAB

Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas.

Privia Health Group NASDAQ:PRVA

$21.14 +0.02 (+0.10%)

As of 10:24 AM Eastern

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest EHAB, PRVA, AVAH, and CLOV Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest EHAB, PRVA, AVAH, and CLOV Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

EHAB, PRVA, AVAH, and CLOV Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

EHAB, PRVA, AVAH, and CLOV Company Descriptions

Aveanna Healthcare NASDAQ:AVAH

Clover Health Investments NASDAQ:CLOV

Enhabit NYSE:EHAB

Privia Health Group NASDAQ:PRVA

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest EHAB, PRVA, AVAH, and CLOV Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest EHAB, PRVA, AVAH, and CLOV Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

EHAB, PRVA, AVAH, and CLOV Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

EHAB, PRVA, AVAH, and CLOV Company Descriptions

Aveanna Healthcare NASDAQ:AVAH

Clover Health Investments NASDAQ:CLOV

Enhabit NYSE:EHAB

Privia Health Group NASDAQ:PRVA

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools